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Available online 13 September 2012AbstractAim: Ilio-inguinal lymph node dissection for stage III melanoma is accompanied by a substantial amount of wound complications. Our
treatment protocols changed in time in terms of postoperative bed rest prescriptions, being in chronological order Group A: 10 days
with a Bohler Braun splint, Group B: 10 days without splint, and Group C: 5 days without splint. The aim of this study was to evaluate
the effect of bed rest prescriptions on wound complications.
Methods: For this study, we included all patients who underwent ilio-inguinal dissection for stage III melanoma in the period 1989e2011.
Both univariate and multivariable analysis were performed to identify factors that were associated with occurrence of wound complications
defined as wound infection, wound necrosis, and seroma.
Results: Of the 204 patients analyzed, 99 suffered one or more wound complications: 51 wound infection, 29 wound necrosis, and 39 se-
roma. A wound complication occurred in 26 out of 64, 51 out of 89, and 22 out of 51 patients for Group A, B, and C, respectively. Uni-
variate analysis showed age >55 ( p ¼ 0.001) and presence of comorbidity ( p ¼ 0.002) to be associated with higher incidence of wound
complications. The 5 day bed rest protocol used in group C did not significantly increase the incidence of wound complications
(ref ¼ Group A: OR ¼ 1.18; 95%CI ¼ 0.52e2.68, p ¼ 0.698).
Conclusion: Early mobilization did not significantly increase the overall wound complication rate after ilio-inguinal lymph node dissection
for melanoma. Age >55 and comorbidity were risk factors in univariate analysis.
 2012 Elsevier Ltd.
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The incidence of melanoma is constantly increasing in
the western world. In the Netherlands the incidence dou-
bled in the past two decades, from 11.3 per 100,000 in
1989 to 26.3 per 100,000 in 2009.1,2 Most of the patients
present initially with Stage I or II melanoma.3 Unfortu-
nately, despite defined surgical treatment of the primary
melanoma with excision margins of 1 or 2 cm, approxi-
mately 16e28% will develop recurrent disease. These re-
currences occur in 20e28% local or in-transit, 15e50%
on distant sites, but most frequently in regional lymph no-
des (26e60%).4* Corresponding author. Tel.: þ31 (0) 50 361 23 17; fax: þ31 (0) 50 361
48 73.
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Open access under the Elsevier OA license.For nodal metastases in the groin region, ilio-inguinal
lymph node dissection is performed. Both clinically detect-
able nodal metastases (macrometastasis) and a positive sen-
tinel lymph node biopsy (micrometastasis) identified by
hematoxylin and eosin staining reflect nodal disease and
are indications for an ilio-inguinal lymph node dissection
in our center. These procedures for stage III melanoma
are accompanied by a substantial amount of wound compli-
cations, with complication rates up to almost 50% in
literature.5e8
Our treatment protocols for ilio-inguinal lymph node
dissection changed in time in terms of postoperative bed
rest prescriptions. In the beginning a 10 day long period
of strict bed rest with the usage of a Bohler Braun splint
was thought to prevent complications by reducing edema
and tension along the wound. Later, with the introduction
of adjustable hospital beds the Bohler Braun splint was
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mained 10 days. In this period more wound healing prob-
lems seemed to occur.7 The protocol was adjusted to
prescription of 5 days of bed rest in the most recent period
following studies that successfully handled early mobiliza-
tion.6,9 Grounds for this adjustment were increasing cost ef-
fectiveness as well as the conviction 10 days of bed rest
would not improve wound healing and could increase the
risk for complications like deep venous thrombosis and pul-
monary embolism. This resulted in three consecutive co-
horts being in chronological order Group A: 10 days with
a Bohler Braun splint, Group B: 10 days without splint,
and Group C: 5 days without splint. The aim of this study
was to evaluate the effect of bed rest prescriptions on early
wound complications.
Patients and methodsPatients and data acquisitionTable 1
Patient characteristics of 204 ilio-inguinal lymph node dissections for stage
III melanoma.
Characteristic n (%)
Gender
Male 99 (48.5)
Female 105 (51.5)
Age, in years, median (range) 56 (5e91)
Breslow thickness (mm)
T1: 1.00 18 (8.8)
T2: 1.01e2.0 49 (24.0)For this retrospective study we included all patients who
underwent ilio-inguinal dissection for stage III melanoma
for both clinically detectable macrometastasis and micro-
metastasis found by sentinel node biopsy in our center dur-
ing the period 1989e2011. Patients who underwent
a superficial dissection solely or in whom additional adju-
vant limb perfusion was performed were excluded. Eventu-
ally, 204 melanoma patients were analyzed in present study.
Characteristics of patient, primary melanoma, operative
procedure, and postoperative period were recorded. Early
wound complications were defined as complications within
30 days of the operative procedure and were divided into
wound infection, wound necrosis and seroma. Wound in-
fection was scored if the wound was opened to drain an ab-
scess, antibiotics were administered, or a positive culture
was found. Wound necrosis was defined as necrotic edges
of the wound which necessitated secondary wound healing
for closure. Seroma was recorded when a puncture was
performed.T3: 2.01e4.0 68 (33.3)
T4: >4.0 49 (24.0)Surgical procedure
Unknown primary 20 (9.9)
Median mm, (range) 2.5 (0.7e20.0)
Ulceration
Present 74 (36.3)
Absent 97 (47.5)
Unknown 33 (16.2)
Indication for dissection
Macrometastasis 152 (74.5)
Micrometastasis 52 (25.5)
Side of dissection
Left 100 (49.0)
Right 104 (51.0)
Risk factors
BMI > 25 110 (53.9)
Smoking 58 (28.4)
Diabetes mellitus 12 (5.9)
Comorbidity 60 (29.4)
Abbreviation: BMI, body mass index.For ilio-inguinal dissection, the superficial lymph nodes
as well as the iliac and obturator lymph nodes were excised
via a single ellipse shaped incision. The sartorius muscle
was used to cover the neurovascular femoral bundle, as de-
scribed extensively in the past.7,10 Since 2004, a single gift
of antibiotic prophylaxis was given before the procedure to
patients in whom sentinel node biopsy was performed pre-
viously. This was introduced to handle the increased risk
for wound infection that was found in patients in whom
lymph node dissection was performed after sentinel lymph
node biopsy.11
All patients were ordered strict bed rest with flexion in
hip and knee for a minimum of 5 days, depending on the
applicable protocol at time of surgical procedure. Flexionin hip and knee in all patients was provided by the Bohler
Braun splint or later by the adjustable hospital beds. Sup-
port stockings were used for mobilization during the first
6 months and low molecular weight heparin was given until
the patient was completely mobilized. Drains were re-
moved after 10 days when the production was less than
20 ml a day. For patients with 5 days of bed rest drains
were mostly removed in the outpatient department.Statistical analysisFrequencies and percentages were used for description
of patient and group characteristics. Differences between
bed rest groups A, B, and C were analyzed by Fischer’s ex-
act test or the chi-square test for categorical variables and
the KruskaleWallis test for continuous variables, all on
a 5% significance level. Association of variables with early
complications was assessed by univariate and multivariable
logistic regression analyses. All variables significant on
a 20% significance level in univariate analysis were entered
in the multivariable analysis to identify factors that were in-
dependently associated with early complications with
a p < 0.050.
Results
In total, we studied 204 patients, consisting of 105 fe-
males and 99 males with a median age of 56 (range
187K.P. Wevers et al. / EJSO 39 (2013) 185e1905e91) years. The indication for ilio-inguinal dissection was
clinically detected macrometastasis in 152 cases and metas-
tasis found by sentinel lymph node biopsy in 52 patients.
More than half of patients (n ¼ 110) had a Body Mass In-
dex (BMI) over 25, 58 patients were smokers, and 12 had
Diabetes Mellitus (Table 1).
As shown in Table 2, differences in the bed rest groups
were the median operative time, the operation year, and me-
dian hospital stay. The median time of procedures for pa-
tients in Group C was 165 (range 110e290) minutes
versus 130 (range 40e280) and 150 (range 75e290) min-
utes ( p < 0.001) for patients in Group A and B,
respectively.
The median hospital stay was significantly shorter in
group C, being 7 (range 5e22) days compared to 14.5
(range 7e34) days in group A and 13 (range 8e45) days
in group B ( p < 0.001). There were no statistically signif-
icant differences between the three groups for age, gender,Table 2
Comparison of clinicopathological characteristics between bed rest groups.
Characteristic Group A 10 days þ Bohler Group
Age
Median (range) 54 (20e80) 54
55 33 (51.6) 47
>55 31 (48.4) 42
Gender
Male 30 (46.9) 45
Female 34 (53.1) 44
Smoking
 44 (68.8) 65
þ 20 (31.3) 24
BMI
Median (range) 25.9 (18.7e39.1) 25.4
<25 25 (39.1) 37
25e30 28 (43.8) 28
>30 9 (14.1) 14
Unknown 2 (3.1) 4
Diabetes mellitus
 61 (95.3) 86
þ 3 (4.7) 3
Comorbidity
 43 (67.2) 66
þ 21 (32.8) 23
Indication
Macrometastasis 46 (71.9) 70
Micrometastasis 18 (28.1) 19
Operative time, min
Median (range) 130 (40e280) 150
150 min 41 (64.1) 46
>150 min 23 (35.9) 43
Surgeon
Fellow 38 (59.4) 63
Staff 26 (40.6) 26
Operation year
1989e2000 59 (92.2) 27
2001e2005 5 (7.8) 43
2006e2011 0 (0) 19
Hospital stay
Median (range) 14.5 (7e34) 13
Abbreviation: BMI, body mass index.
p-values <0.05 are in bold.smoking, BMI, diabetes mellitus, total comorbidity, and in-
dication for the procedure.Early wound complicationsOverall, 99 patients suffered one or more wound compli-
cations. A wound infection occurred in 51 patients, wound
necrosis was seen in 29 patients, and a seroma puncture was
performed in 39 patients.
One or more wound complications occurred in 26 out of
64, in 51 out of 89, and in 22 out of 51 patients for Group
A, B, and C ( p ¼ 0.085), respectively. Multivariable anal-
ysis revealed age >55 (OR ¼ 2.25; 95%CI ¼ 1.19e4.25,
p ¼ 0.01) and bed rest Group B (ref ¼ Group A:
OR ¼ 2.72; 95%CI ¼ 1.32e5.61, p ¼ 0.007) to be indepen-
dently associated with occurrence of one or more wound
complications. The rate of one or more complications in
Group C did not significantly differ from the referenceB 10 days Group C 5 days p
(22e86) 60 (5e91) 0.172
(52.8) 18 (35.3)
(47.2) 33 (64.7)
(50.6) 27 (52.9) 0.877
(49.4) 24 (47.1)
(73.0) 37 (72.5) 0.832
(27.0) 14 (27.5)
(18.6e38.1) 25.2 (13.5e53.9) 0.724
(43.5) 25 (49.0)
(40.0) 16 (31.4)
(16.5) 9 (17.6)
(4.5) 1 (2.0)
(96.6) 45 (88.2) 0.138
(3.4) 6 (11.8)
(74.2) 35 (68.6) 0.607
(25.8) 16 (31.4)
(78.7) 36 (70.6) 0.484
(21.3) 15 (29.4)
(75e290) 165 (110e290) <0.001
(51.7) 22 (43.1)
(48.3) 29 (56.9)
(70.8) 21 (41.2) 0.003
(29.2) 30 (58.8)
(30.3) 0 (0) <0.001
(48.3) 2 (3.9)
(21.3) 49 (96.1)
(8e45) 7 (5e22) <0.001
Table 3
Univariate and multivariable analysis of characteristics associated with postoperative complications.
Characteristic One or more complications Multivariable analysis
p OR (95%CI)
Wound infection Multivariable analysis,
p OR (95%CI)
Wound necrosis Multivariable analysis
p OR (95%CI)
Seroma Multivariable analysis
p OR (95%CI)
n/total n (%) p n/total n (%) p n/total n (%) p n/total n (%) p
Age 0.012 0.179 0.141
55 36/98 (36.7) 0.001 1 19/98 (19.4) 0.075 1 12/98 (12.2) 0.438 14/98 (14.3) 0.092 1
>55 63/106 (63.6) 2.25 (1.19e4.25) 32/106 (30.2) 1.62 (0.80e3.27) 17/106 (16.0) 25/106 (23.6) 1.73 (0.83e3.60)
Gender
Male 50/99 (50.5) 0.584 27/99 (27.3) 0.467 16/99 (16.2) 0.440 19/105 (18.1) 0.702
Female 49/105 (46.7) 24/105 (22.9) 13/105 (12.4) 20/99 (20.2)
Smoking 0.246
 71/146 (48.6) 0.964 40/146 (27.4) 0.210 17/146 (11.6) 0.095 1 31/146 (21.2) 0.223
þ 28/58 (58.3) 11/58 (19.0) 12/58 (20.7) 1.73 (0.69e4.35) 8/58 (13.8)
BMI 0.149 0.018 0.162
<25 34/87 (39.1) 0.055 1 13/87 (14.9) 0.003 1 7/87 (8.0) 0.065 1 17/87 (19.5) 0.553
25e30 45/78 (57.7) 1.91 (0.98e3.72) 26/78 (33.3) 2.60 (1.21e5.59) 14/78 (17.9) 2.22 (0.78e6.26) 17/78 (21.8)
>30 17/32 (53.1) 1.63 (0.69e3.87) 12/32 (37.5) 3.25 (1.27e8.29) 6/32 (18.8) 3.12 (0.87e11.16) 4/32 (12.5)
Diabetes mellitus 0.734 0.082
 99/192 (47.4) 0.195 1 48/192 (25.0) 1.000 28/192 (14.6) 0.548 34/192 (17.7) 0.041 1
þ 8/12 (66.7) 1.27 (0.32e5.13) 3/12 (25.0) 1/12 (8.3) 5/12 (41.7) 2.96 (0.87e10.02)
Comorbidity 0.085 0.315 0.103
 60/144 (41.7) 0.002 1 31/144 (21.5) 0.076 1 17/144 (11.8) 0.127 1 25/144 (17.4) 0.323
þ 39/60 (65.0) 1.96 (0.91e4.21) 20/60 (33.3) 1.45 (0.70e3.01) 12/60 (20.0) 2.16 (0.86e5.46) 14/60 (23.3)
Indication
Micrometastasis 24/52 (46.2) 0.691 16/52 (30.8) 0.266 9/52 (17.3) 0.459 7/52 (13.5) 0.230
Macrometastasis 75/152 (49.3) 35/152 (23.0) 20/152 (13.2) 32/152 (21.1)
Operative time
150 min 51/109 (46.8) 0.594 26/109 (23.9) 0.685 14/109 (12.8) 0.548 19/109 (17.4) 0.512
>150 min 47/99 (50.5) 25/95 (26.3) 15/95 (15.8) 20/95 (21.1)
Surgeon
Fellow 63/122 (51.6) 0.278 33/122 (27.0) 0.410 19/122 (15.6) 0.498 24/122 (19.7) 0.806
Staff 36/82 (43.9) 18/82 (22.0) 10/82 (12.2) 15/82 (18.3)
Operation year 0.421
1989e2000 39/86 (45.3) 0.304 17/86 (19.8) 0.333 14/86 (16.3) 0.117 1 18/86 (20.9) 0.780
2001e2005 29/50 (58.0) 14/50 (28.0) 10/50 (20.0) 0.58 (0.19e1.79) 8/50 (16.0)
2006e2011 31/68 (45.6) 20/68 (29.4) 5/68 (7.4) 0.37 (0.08e1.78) 13/68 (19.1)
Bed rest group 0.013 0.004
A: 10d ays
þ Bohler
26/64 (40.6) 0.085 1 13/64 (20.3) 0.395 6/64 (9.4) 0.002 1 12/64 (18.8) 0.712
B: 10 days 51/89 (57.3) 2.72 (1.32e5.61) 22/89 (24.7) 21/89 (23.6) 6.46 (1.82e22.93) 19/89 (21.3)
C: 5 days 22/51 (43.1) 1.18 (0.52e2.68) 16/51 (31.4) 2/51 (3.9) 1.22 (0.13e11.28) 8/51 (15.7)
Abbreviation: BMI, body mass index.
p-values <0.05 are in bold.
All variables significant on a 20% significance level were entered in the multivariable analysis.
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(Table 3). There were no significant differences for occur-
rence of wound infections and seroma in the bed rest
groups. Wound necrosis was most frequently seen in Group
B (Table 3).
In multivariable analysis, higher BMI was associated
with the occurrence of wound infections ( p ¼ 0.018). For
wound necrosis, the bed rest group was the only factor as-
sociated in multivariable analysis, showing more wound ne-
crosis in Group B ( p ¼ 0.004). No variable was
significantly associated with occurrence of seroma in mul-
tivariable analysis (Table 3).
Discussion
In the present study, early mobilization after 5 days fol-
lowing ilio-inguinal dissection for stage III melanoma did
not increase the wound complication rate. We found both
10 days bed rest without usage of a Bohler Braun splint
and age above 55 years to be associated with a higher oc-
currence of one or more wound complications. The early
complication rate of 99 out of 204 found in this study is
within the range of complication rates reported in literature
for ilio-inguinal dissections.5e8Bed rest protocolsBed rest of 10 days with usage of a Bohler Braun splint
was associated with the lowest overall complication rate: in
group A 26 out of 64 patients had one or more complications.
The most recent 5 day bed rest regimen currently used in our
center (group C) did not show a significant increase, com-
pared to group A, in early wound complication rate (22 out
of 51 patients; OR ¼ 1.18; 95%CI ¼ 0.52e2.68). A 10 day
bed rest without the usage of a splint (group B) resulted in
a significantly higher complication rate compared to group
A (51 out of 89 patients; OR ¼ 2.72 95%CI ¼ 1.32e5.61)
(Table 3). The higher complication rate found for group B
was mostly formed by the high rate of wound necrosis in
this group, with unknown cause.
Although the exact reasons for the differences in compli-
cation rates are not clear, they seem to justify mobilization
of melanoma patients 5 days after ilio-inguinal dissection.Other risk factorsThe increased risk for wound infections with a high BMI
is well known for many surgical procedures as well as for
groin dissections in melanoma patients.12e14 The wound in-
fection rate in this study was increased in patients who had
overweight (BMI > 25) and was even higher in patients
who were obese (BMI > 30). In patients with a sentinel
node biopsy preceding the ilio-inguinal dissection, 16 out
of 52 suffered a wound infection compared to 35 out of
152 patients operated on for a macrometastasis
( p ¼ 0.266). This wound infection rate for patientsoperated on for a positive sentinel node was not reduced de-
spite of the perioperative antibiotic prophylaxis adminis-
tered since 2004 in our center.11 The wound necrosis rate
was significantly lower in the 5 day bed rest group. Seroma
was more frequently seen in diabetic patients (34 out of 192
versus 5 out of 12 in non-diabetics), although this was only
significant in univariate analysis.Future perspectivesThe results of this study show that reducing the pre-
scribed days of bed rest from 10 to 5 days after ilio-
inguinal dissection for melanoma is feasible and does not
significantly increase the early wound complication rate.
Moreover, a 5 day bed rest regimen was associated with
a significantly shorter hospital stay and could therefore con-
tribute to increase cost-effectiveness of this surgical proce-
dure. Moreover, early mobilization of patients will reduce
morbidity related to prolonged immobility (like venous
thromboembolic events), although our cohort was too small
to study these specific complications. In the future, even
further reducing bed-rest and hospital day could be ex-
plored. Because no scientific data is available, we would
recommend studying complication rates after 3 days of
bed rest, before further reducing bed rest protocols. In
our opinion a Bohler Braun splint is obsolete and patients
often experience discomfort. Therefore we discourage its
use in future practice.LimitationsLimitations of this study are associated with its retro-
spective character. Although complications seen in the out-
patient department within 30 days were included in the
analysis, there could have been under-registration of minor
complications, especially in the 5 day bed rest group.
Maybe, this phenomenon accounts for the differences in
wound necrosis rates between group B and C.
Some other centers may already mobilize their patients
after 3, 2, or even one day, which could make the results
of the present study not applicable to their situation.
However, we feel that reducing bed rest to only 3 or less
days can only be justified after monitoring complication
rates after previous changes in bed rest protocols, as pre-
sented in this study.ConclusionsOverall, an ilio-inguinal dissection is a demanding pro-
cedure requiring ‘surgical skills’ to reduce the overall com-
plication rate, which is probably caused by impaired
arterial blood supply through to thin skin flaps. In this
study, older age, prolonged bed rest without Bohler Braun
splint usage and higher BMI were independently associated
with a complicated course following ilio-inguinal lymph
node dissection for melanoma. Changing ‘bed rest
190 K.P. Wevers et al. / EJSO 39 (2013) 185e190protocols’ to 5 days without Bohler Braun splint usage, did
not significantly increase the incidence of complications.
The application of a short bed rest protocol could possibly
increase cost-effectiveness of the ilio-inguinal lymph node
dissection for melanoma.
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